Burning mouth syndrome and secondary oral burning

Otolaryngologic Clinics of North America

Volumn 44, Issue 1, 2011, Pages 205-219

  Minor, Jacob S ^a   Epstein, Joel B ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Burning mouth syndrome; Glossodynia; Neuropathy; Stomatopyrosis; Taste change; Xerostomia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; CAPSAICIN; CHLORDIAZEPOXIDE; CLONAZEPAM; GABAPENTIN; HYPERICUM PERFORATUM EXTRACT; LAFUTIDINE; PAROXETINE; SERTRALINE; SUCRALFATE; THIOCTIC ACID;

BEHAVIOR THERAPY; BURNING MOUTH SYNDROME; COGNITIVE THERAPY; ENDOCRINE DISEASE; GLOSSODYNIA; GROUP THERAPY; HORMONE SUBSTITUTION; HUMAN; MENTAL DISEASE; MOUTH EXAMINATION; MOUTH OCCLUSION PRESSURE; PERIPHERAL NEUROPATHY; PHANTOM PAIN; POSTMENOPAUSE; PREVALENCE; PROGNOSIS; REVIEW; SEX RATIO; TASTE; XEROSTOMIA;

BURNING MOUTH SYNDROME; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 78549257402     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.09.008     Document Type: Review

References (92)

1. Klasser G.D., Fischer D.J., Epstein J.B. Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am 2008, 20(2):255-271. vii.
2. Maltsman-Tseikhin A., Moricca P., Niv D. Burning mouth syndrome: will better understanding yield better management?. Pain Pract 2007, 7(2):151-162.
3. Sardella A. An up-to-date view on burning mouth syndrome. Minerva Stomatol 2007, 56(6):327-340.
4. Zakrzewska J.M., Forssell H., Glenny A.M. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain 2003, 17(4):293-300.
5. Clark G.T., Minakuchi H., Lotaif A.C. Orofacial pain and sensory disorders in the elderly. Dent Clin North Am 2005, 49(2):343-362.
6. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987, 63(1):30-36.
7. Society I.H. The international classification of headache disorders, 2nd edition. Cephalalgia 2004, 24(Suppl 1):1-160.
8. Fox H. Burning tongue glossodynia. N Y State J Med 1935, 35:881-884.
9. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms 1994, 74-75. IASP Press, Seattle (WA). 2nd edition. B.N. Merskey (Ed.).
10. WHO World health organization international classification of diseases and related health problems 2009 Available at:, Accessed March 28, 2010. http://www.icd9data.com/2009/Volume1/520-579/520-529/529/default.htm.
11. Gorsky M., Silverman S., Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surg Oral Med Oral Pathol 1991, 72(2):192-195.
12. Bergdahl M., Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999, 28(8):350-354.
13. Cerchiari D.P., de Moricz R.D., Sanjar F.A., et al. Burning mouth syndrome: etiology. Braz J Otorhinolaryngol 2006, 72(3):419-423.
14. Chimenos-Kustner E., Marques-Soares M.S. Burning mouth and saliva. Med Oral 2002, 7(4):244-253.
15. Just T., Steiner S., Pau H.W. Oral pain perception and taste in burning mouth syndrome. J Oral Pathol Med 2009, 4:4.
16. Lamey P.J., Lamb A.B., Hughes A., et al. Type 3 burning mouth syndrome: psychological and allergic aspects. J Oral Pathol Med 1994, 23(5):216-219.
17. Lipton J.A., Ship J.A., Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993, 124(10):115-121.
18. Basker R.M., Sturdee D.W., Davenport J.C. Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J 1978, 145(1):9-16.
19. Tammiala-Salonen T., Hiidenkari T., Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 1993, 21(2):67-71.
20. Wardrop R.W., Hailes J., Burger H., et al. Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989, 67(5):535-540.
21. Forssell H., Jaaskelainen S., Tenovuo O., et al. Sensory dysfunction in burning mouth syndrome. Pain 2002, 99(1-2):41-47.
22. Frutos R., Rodriguez S., Miralles-Jorda L., et al. Oral manifestations and dental treatment in menopause. Med Oral 2002, 7(1):26-30. 31-5.
23. Jaaskelainen S.K., Forssell H., Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997, 73(3):455-460.
24. Lauria G., Majorana A., Borgna M., et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005, 115(3):332-337.
25. Borelli V., Marchioli A., Di Taranto R., et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Oral Dis 2010, 16(4):365-374.
26. Albuquerque R.J., de Leeuw R., Carlson C.R., et al. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006, 122(3):223-234.
27. Jaaskelainen S.K., Rinne J.O., Forssell H., et al. Role of the dopaminergic system in chronic pain-a fluorodopa-PET study. Pain 2001, 90(3):257-260.
28. Hagelberg N., Forssell H., Rinne J.O., et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003, 101(1-2):149-154.
29. Bartoshuk L.M., Snyder D.J., Grushka M., et al. Taste damage previously unsuspected consequences. Chem Senses 2005, 30(Suppl 1):i218-i219.
30. Grushka M., Epstein J., Mott A. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 86(5):557-561. [Evidence Grade B].
31. Femiano F., Lanza A., Buonaiuto C., et al. Burning mouth disorder (BMD) and taste: a hypothesis. Med Oral Patol Oral Cir Bucal 2008, 13(8):E470-E474.
32. Eliav E., Kamran B., Schaham R., et al. Evidence of chorda tympani dysfunction in patients with burning mouth syndrome. J Am Dent Assoc 2007, 138(5):628-633.
33. Formaker B.K., Mott A.E., Frank M.E. The effects of topical anesthesia on oral burning in burning mouth syndrome. Ann N Y Acad Sci 1998, 855:776-780.
34. Grushka M., Bartoshuk L.M. Burning mouth syndrome and oral dysesthesias. Can J Diagnos 2000, 17:99-109.
35. Bartoshuk L.M., Kveton J., Lehman C. Peripheral source of taste phantom (i.e., dysgeusia) demonstrated by topical anesthesia. Chem Senses 1991, 16(5):499-500.
36. Tie K., Fast K., Kveton J., et al. Anesthesia of chorda tympani nerve and effect on oral pain. Chem Senses 1999, 24:609.
37. Small D.M., Apkarian A.V. Increased taste intensity perception exhibited by patients with chronic back pain. Pain 2006, 120(1-2):124-130.
38. Fox A.L. Six in ten "tasteblind" to bitter chemical. Sci News 1931, 9:249.
39. Reed D.R., Nanthakumar E., North M., et al. Localization of a gene for bitter-taste perception to human chromosome 5p15. Am J Hum Genet 1999, 64(5):1478-1480.
40. Gremeau-Richard C., Dubray C., Aublet-Cuvelier B., et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010, 149(1):27-32.
41. Lamey P.J., Lamb A.B. The usefulness of the HAD scale in assessing anxiety and depression in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1989, 67(4):390-392.
42. Maina G., Albert U., Gandolfo S., et al. Personality disorders in patients with burning mouth syndrome. J Personal Disord 2005, 19(1):84-93.
43. Rojo L., Silvestre F.J., Bagan J.V., et al. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 1993, 75(3):308-311.
44. Bogetto F., Maina G., Ferro G., et al. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 1998, 60(3):378-385.
45. Browning S., Hislop S., Scully C., et al. The association between burning mouth syndrome and psychosocial disorders. Oral Surg Oral Med Oral Pathol 1987, 64(2):171-174.
46. Eli I., Kleinhauz M., Baht R., et al. Antecedents of burning mouth syndrome (glossodynia)-recent life events vs. psychopathologic aspects. J Dent Res 1994, 73(2):567-572.
47. Feinmann C., Harris M., Eli I., et al. Psychogenic facial pain. Part 2: management and prognosis. Br Dent J 1984, 156(6):205-208.
48. Feinmann C., Harris M., Eli I., et al. Psychogenic facial pain. Part 1: the clinical presentation. Br Dent J 1984, 156(5):165-168.
49. Lamey P.J., Lewis M.A. Oral medicine in practice: burning mouth syndrome. Br Dent J 1989, 167(6):197-200.
50. Pisanty S., Rafaely B., Polishuk W. The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol 1975, 40(3):346-353.
51. Woda A., Dao T., Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009, 23(3):202-210.
52. Danhauer S.C., Miller C.S., Rhodus N.L., et al. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain 2002, 16(4):305-311.
53. Kho H.S., Lee J.S., Lee E.J., et al. The effects of parafunctional habit control and topical lubricant on discomforts associated with burning mouth syndrome (BMS). Arch Gerontol Geriatr 2009, 21:21. [Evidence Grade B].
54. Marino R., Capaccio P., Pignataro L., et al. Burning mouth syndrome: the role of contact hypersensitivity. Oral Dis 2009, 15(4):255-258.
55. Toida M., Kato K., Makita H., et al. Palliative effect of lafutidine on oral burning sensation. J Oral Pathol Med 2009, 38(3):262-268. [Evidence Grade A].
56. Buchanan J., Zakrzewska J. Burning mouth syndrome. Clin Evid (Online) 2008, 3:1301-1307.
57. Sardella A., Lodi G., Demarosi F., et al. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006, 12(2):152-155.
58. Zakrzewska J.M., Forssell H., Glenny A.M. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005, 1. CD002779.
59. Woda A., Navez M.L., Picard P., et al. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 1998, 12(4):272-278. [Evidence Grade B].
60. Gremeau-Richard C., Woda A., Navez M.L., et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004, 108(1-2):51-57. [Evidence Grade A].
61. Yamazaki Y., Hata H., Kitamori S., et al. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107(1):e6-11. [Evidence Grade B].
62. Maina G., Vitalucci A., Gandolfo S., et al. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002, 63(1):38-43. [Evidence Grade B].
63. Heckmann S.M., Heckmann J.G., Ungethum A., et al. Gabapentin has little or no effect in the treatment of burning mouth syndrome-results of an open-label pilot study. Eur J Neurol 2006, 13(7):e6-e7. [Evidence Grade B].
64. Ziegler D., Hanefeld M., Ruhnau K.J., et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 1999, 22(8):1296-1301.
65. Carbone M., Pentenero M., Carrozzo M., et al. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009, 120(1-2):492-496. [Evidence Grade A].
66. Lopez-Jornet P., Camacho-Alonso F., Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009, 36(1):52-57. [Evidence Grade A].
67. Bergdahl J., Anneroth G., Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995, 24(5):213-215. [Evidence Grade B].
68. Miziara I.D., Filho B.C., Oliveira R., et al. Group psychotherapy: an additional approach to burning mouth syndrome. J Psychosom Res 2009, 67(5):443-448. [Evidence Grade B].
69. Femiano F. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol 2002, 51(9):405-409. [Evidence Grade B].
70. Femiano F., Gombos F., Scully C., et al. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000, 6(5):274-277. [Evidence Grade B].
71. Femiano F., Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002, 31(5):267-269. [Evidence Grade A].
72. Cavalcanti D.R., da Silveira F.R. Alpha lipoic acid in burning mouth syndrome-a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009, 38(3):254-261. [Evidence Grade A].
73. Tammiala-Salonen T., Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 1999, 13(2):83-88. [Evidence Grade A].
74. Cole J.A., Ephross S.A., Cosmatos I.S., et al. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007, 16(10):1075-1085.
75. Epocrates. Clonazepam; 2010. Available at:. Accessed March 28, 2010. https://online.epocrates.com/noFrame/showPage.do%3fmethod=drugs&MonographId=182.
76. Epocrates. Chlordiazepoxide; 2010. Available at: Accessed March 28, 2010. https://online.epocrates.com/noFrame/showPage.do%3fmethod=drugs&MonographId=171.
77. Grushka M., Epstein J.B., Gorsky M. Burning mouth syndrome. Am Fam Physician 2002, 65(4):615-620.
78. White T.L., Kent P.F., Kurtz D.B., et al. Effectiveness of gabapentin for treatment of burning mouth syndrome. Arch Otolaryngol Head Neck Surg 2004, 130(6):786-788.
79. FDA.Drugs@FDA Available at:, Accessed March 28, 2010. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.
80. Sardella A., Uglietti D., Demarosi F., et al. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 88(6):683-686.
81. Epstein J.B., Marcoe J.H. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994, 77(2):135-140.
82. Lauritano D., Spadari F., Formaglio F., et al. Etiopathogenic, clinical-diagnostic and therapeutic aspects of the burning mouth syndrome-research and treatment protocols in a patient group. Minerva Stomatol 1998, 47(6):239-251.
83. Campisi G., Spadari F., Salvato A. Minerva Stomatol 1997, 46(6):297-305. [in Italian].
84. Sardella A., Lodi G., Demarosi F., et al. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med 2008, 37(7):395-401.
85. Bonfils P., Peignard P., Malinvaud D. Cognitive-behavioral therapy in the burning mouth syndrome-a new approach. Ann Otolaryngol Chir Cervicofac 2005, 122(3):146-149.
86. Humphris G.M., Longman L.P., Field E.A. Cognitive-behavioural therapy for idiopathic burning mouth syndrome: a report of two cases. Br Dent J 1996, 181(6):204-208.
87. Siniscalchi A., Gallelli L., Marigliano N.M., et al. Use of topiramate for glossodynia. Pain Med 2007, 8(6):531-534.
88. Demarosi F., Tarozzi M., Lodi G., et al. The effect of levosulpiride in burning mouth syndrome. Minerva Stomatol 2007, 56(1-2):21-26.
89. Stuginski-Barbosa J., Rodrigues G.G., Bigal M.E., et al. Burning mouth syndrome responsive to pramipexol. J Headache Pain 2008, 9(1):43-45.
90. Bjorne A. Assessment of temporomandibular and cervical spine disorders in tinnitus patients. Prog Brain Res 2007, 166:215-219.
91. Kaltenbach J.A. The dorsal cochlear nucleus as a contributor to tinnitus: mechanisms underlying the induction of hyperactivity. Prog Brain Res 2007, 166:89-106.
92. Rocha C.A., Sanchez T.G. Myofascial trigger points: another way of modulating tinnitus. Prog Brain Res 2007, 166:209-214.